Mirae Asset Global Investments’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.1K | Buy |
15,439
+2,219
| +17% | +$11.2K | ﹤0.01% | 1180 |
|
|
2025
Q1 | $76.8K | Buy |
13,220
+499
| +4% | +$2.9K | ﹤0.01% | 1158 |
|
|
2024
Q4 | $94K | Sell |
12,721
-74,818
| -85% | -$553K | ﹤0.01% | 1159 |
|
|
2024
Q3 | $611K | Buy |
87,539
+80,664
| +1,173% | +$563K | ﹤0.01% | 926 |
|
|
2024
Q2 | $52.1K | Sell |
6,875
-90,669
| -93% | -$687K | ﹤0.01% | 1242 |
|
|
2024
Q1 | $738K | Sell |
97,544
-8,128
| -8% | -$61.5K | ﹤0.01% | 1699 |
|
|
2023
Q4 | $1.04M | Sell |
105,672
-682
| -0.6% | -$6.73K | ﹤0.01% | 1597 |
|
|
2023
Q3 | $814K | Buy |
106,354
+25,178
| +31% | +$193K | ﹤0.01% | 1632 |
|
|
2023
Q2 | $605K | Sell |
81,176
-3,683
| -4% | -$27.5K | ﹤0.01% | 1858 |
|
|
2023
Q1 | $566K | Buy |
84,859
+14,219
| +20% | +$94.8K | ﹤0.01% | 1863 |
|
|
2022
Q4 | $545K | Buy |
70,640
+476
| +0.7% | +$3.67K | ﹤0.01% | 1838 |
|
|
2022
Q3 | $747K | Buy |
70,164
+33,161
| +90% | +$353K | ﹤0.01% | 1649 |
|
|
2022
Q2 | $301K | Buy |
+37,003
| New | +$301K | ﹤0.01% | 1987 |
|